AMI Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-19,070
Closed -$1.03M 78
2017
Q4
$1.03M Sell
19,070
-3,361
-15% -$184K 0.07% 71
2017
Q3
$1.28M Buy
+22,431
New +$1.31M 0.09% 71

Other funds holding BIVV

AMI Asset Management's BIVV Position: Q1 2018 in Review

AMI Asset Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 19,070 shares — an estimated $1.03M sold.

AMI Asset Management first reported a position in BIVV in Q3 2017 and held it in 2 quarters. The position peaked at $1.28M in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • AMI Asset Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • AMI Asset Management sold 19,070 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $1.03M.
  • AMI Asset Management first reported a position in Bioverativ Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • AMI Asset Management's Bioverativ Inc. Common Stock position peaked at $1.28M in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on AMI Asset Management's 13F filing for Q1 2018, filed 20 Apr 2018.